The DOI matches its Crossref record.
Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
Abstract
The theoretical basis for using radioligand binding and pharmacological techniques to estimate the dissociation constants of drugs which interact allosterically with receptors is described. This theory predicts that an allosteric ligand changes the affinity of another ligand which binds at the primary recognition site on the receptor complex without affecting the binding capacity of the primary ligand. The magnitude of this effect depends on the amount of cooperativity (positive or negative) between the binding of ligands at the allosteric and primary recognition sites. It is possible to estimate the dissociation constant of an allosteric ligand by measuring its effect on the binding of a radioligand at a fixed concentration. In this situation, the dissociation constant of the allosteric ligand can be calculated from the concentration of ligand which causes half of its maximal effect on radioligand binding. The effects of an allosteric ligand on the pharmacological responses to an agonist can be attributed to changes in affinity and intrinsic efficacy of the agonist-receptor complex. If the agonist used in the pharmacological experiments has a large receptor reserve, or if the allosteric ligand only influences the affinity of the agonist, then the dissociation constant of the allosteric ligand can be calculated from the results of experiments in which the concentration of agonist required for half-maximal response (EC50) is measured in the presence of various concentrations of the allosteric ligand. If the agonist used in the pharmacological experiments is a partial agonist with little receptor reserve, then the shift in the EC50 of the agonist caused by the allosteric ligand may be dependent on the affinity of the agonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Metadata
- Authors
- Ehlert, F. J.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1988-02
- Volume
- 33
- Issue
- 2
- Pages
- 187-194
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2158066978
- Cited by
- 351
- References
- 0
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. https://app.cochat.ai/papers/10.1016/s0026-895x(25)13145-3
- The paper
- Ehlert, F. J. (1988). Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Molecular Pharmacology. https://doi.org/10.1016/s0026-895x(25)13145-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.